NanoFocusRay, an industry-academic cooperation company of Wonkwang University Hospital, said that it has exported Phion 2.0, its mobile computed tomography (CT) device for Covid-19, to Iran.
The device is a portable, low-dose mobile CT that saves time and money by diagnosing Covid-19 patients in an isolated ward, also reducing the risk of infection by minimizing contact with other patients, the company said.
The device also reduces the radiation dose to a quarter level of conventional CTs while providing excellent images based on artificial intelligence image processing technology.
|A patient using the NanoFocusRay’s Phion 2.0 at a negative ward in Wonkwang University Hospital (left) and an image reading provided by the device. (Wonkwang University Hospital)|
Mobile chest CT is much more sensitive than the molecular diagnostics method of reverse transcription-polymerase chain reaction tests (RT-PCT) and has 90 percent higher diagnostic accuracy than existing mobile X-rays," the company said. "This makes the device an essential part of diagnosing Covid-19 patients."
NanoFocus Ray plans to install the device at a national hospital in Iran suffering from the shortage of medical devices. After providing the device's merits, the company plans to expand the device to the rest of that country.
“Besides, the company seeks to export it to Belgium, France, Turkey, and Indonesia from in the second half of this year,” said Yoon Kwon-ha, president of NanoFocusRay and Wonkwang University Hospital.
As this is a critical time to fight off Covid-19, the company hopes that Korea's mobile CT will be distributed worldwide to protect human health, Yoon added.
<© Korea Biomedical Review, All rights reserved.>